Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Other material
confidence 55%
filed 2026-05-19
Item 8.01
The filing discloses a shareholder letter and corporate update issued on May 18, 2026, but the Item 8.01 text itself provides no substantive detail about the content or nature of the update. Without access to Exhibit 99.1, the specific event cannot be precisely classified. Given that a formal shareholder letter and corporate update warrant 8-K disclosure, the event is presumed material, but the lack of descriptive language in the Item text prevents confident assignment to a more specific category.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-05-19
Item 2.02
The filing discloses a press release issued on May 13, 2026 announcing financial results for the quarter ended March 31, 2026, with an earnings call conducted on May 15, 2026. This is a standard quarterly earnings release disclosure under Item 2.02, which is material to investors as it provides the registrant's financial performance for the period.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-19
Item 8.01
Amesite Inc. announced securing a major new enterprise customer with a 2,700-patient census, described as "its largest deployment to date and a major milestone in validating its enterprise strategy." While this is a significant business development, it does not fit neatly into the standard event taxonomy (not an earnings release, M&A activity, or other defined categories). The disclosure is material to investors as it demonstrates validation of the company's enterprise strategy and represents a substantial customer win, but the event type is best classified as other_material given the absence of a more specific category.
View raw filing on EDGAR →
8-K
M&A activity
confidence 96%
filed 2026-05-19
Item 1.01
InMed Pharmaceuticals entered into a definitive merger agreement with Mentari Therapeutics on May 19, 2026, whereby Mentari shareholders will receive approximately 98.49% of the combined company post-closing. The transaction contemplates a $125 million equity valuation for Mentari and involves a two-step merger structure with concurrent $150 million financing, constituting a material change of control requiring shareholder approval and SEC registration.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-05-19
Item 2.02
The filing discloses completion of a material acquisition (the "Merger") of Corvex Legacy Holdings, Inc. by Movano Inc. (now renamed Corvex, Inc.) on March 19, 2026, pursuant to an Amended and Restated Merger Agreement. Although Item 2.02 typically covers financial results, the substance of this disclosure is the consummation of a merger transaction with pro forma financial statements, which is a classic M&A activity event. The filing explicitly references the Merger Agreement and provides pro forma combined financial statements as if the merger had occurred on January 1, 2026/2025, confirming this is a material acquisition completion.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-19
Item 5.03
Onconetix implemented a 1-for-10 reverse stock split effective May 21, 2026, approved by stockholders and undertaken primarily to achieve Nasdaq minimum bid price compliance. This material capital structure event reduces outstanding shares and mitigates delisting risk.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-05-19
Item 2.02 explicitly discloses financial results for the quarter ended March 31, 2026, with a press release furnished as Exhibit 99.1. This is a standard quarterly earnings announcement, which is material to investors assessing the registrant's operational performance and financial condition.
View raw filing on EDGAR →
8-K
Other material
confidence 70%
filed 2026-05-19
Item 1.01
MSP Recovery entered into two material funding agreements on May 15, 2026: a $0.1 million discretionary advance from Hazel Partners under an existing working capital facility and a $0.1 million one-time advance from VRM MSP Recovery Partners to support accounts payable. These discretionary and one-time advances reflect liquidity constraints and financial stress.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-05-19
Item 8.01
MSP Recovery received notice from OTC Markets that its Class A common stock will be downgraded from the OTCQB Venture Market to the OTC Pink market effective May 20, 2026, due to failure to timely file its Form 10-K and OTCQB Annual Certification. The downgrade could adversely affect liquidity, market price, analyst coverage, and investor access.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-05-19
Item 5.07
Shareholders voted on a Charter Amendment Proposal at an Extraordinary General Meeting on April 10, 2026, approving the amendment with 3,308,619 votes in favor and 2,861,341 against. The vote resulted in 5,333,287 ordinary shares being tendered for redemption in connection with the approval.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-19
Item 5.03
The Company's charter was amended to extend the business combination deadline by 12 months from June 16, 2026 to June 16, 2027, following shareholder approval. The Sponsor concurrently entered into an assignment of economic interest agreement with a third party to secure votes for the amendment in exchange for transferring 50,000 Class B shares post-business combination.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 45%
filed 2026-05-19
The filing discloses a Board-approved proposal to add PineBridge as an additional investment sub-adviser, subject to shareholder approval at a special meeting scheduled for July 30, 2026. However, this is a pre-vote disclosure (Item 8.01, Other Events) announcing the proposal and soliciting material, not a report of actual shareholder vote results. The checkbox for "Soliciting material pursuant to Rule 14a-12" is marked, confirming this is proxy solicitation material rather than a vote outcome. The event is material as it involves a significant change to the Fund's investment strategy and sub-advisory structure, but the event_type is ambiguous—this could also be classified as "other_material" since it does not fit the shareholder_vote_results category (which reports results after voting has occurred).
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 45%
filed 2026-05-19
The filing discloses a Board-approved change in investment sub-adviser (King Street Sub-Adviser replacing Octagon Credit Investors) that requires shareholder approval at a special meeting scheduled for July 30, 2026. While the filing is primarily a solicitation of proxies (Item 8.01, Other Events) announcing the proposed change and calling for shareholder vote, it does not yet report actual vote results. The material event is the proposed sub-adviser change and the upcoming shareholder vote, which is significant to investors in this closed-end fund.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-05-19
Item 7.01
The filing discloses a letter to stockholders regarding "the potential acquisition of certain assets and intellectual property of BullionFX Ltd." This describes entry into or contemplation of a material acquisition transaction. Although the language uses "potential," the fact that the company issued a formal stockholder letter and filed it on 8-K indicates materiality. The acquisition of assets and IP from another entity constitutes M&A activity under Item 1.01/2.01 framework, even if still in preliminary stages.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-05-19
This 8-K discloses the consummation of an initial public offering (IPO) on May 18, 2026, with the registration statement declared effective on May 14, 2026. The Company raised $150 million in gross proceeds from the sale of 15 million units at $10.00 per unit, plus an additional $5.375 million from a concurrent private placement of warrants. While technically an IPO rather than a traditional M&A transaction, the filing is structured around Item 1.01 (Entry into a Material Definitive Agreement) and involves multiple material agreements (underwriting, warrant, registration rights, etc.) that constitute the foundational capital-raising event. The closest taxonomy fit is ma_activity, as this represents a material capital transaction and change of control event (transition from private to public company), though the event could also be characterized as a dilutive_issuance given the warrant components and private placement structure.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-19
Item 8.01
This disclosure concerns a proxy contest at Vaxart's 2026 Annual Meeting, where the Company is urging shareholders to support its six director nominees against three dissident candidates nominated by a shareholder. While proxy contests and shareholder activism can materially affect governance and strategic direction, this Item 8.01 disclosure does not fit neatly into the specific event categories (e.g., shareholder_vote_results applies to vote outcomes, not pre-vote solicitations). The disclosure is material because it signals potential control challenges and governance uncertainty, but the absence of a dedicated taxonomy category for proxy contests or shareholder activism makes "other_material" the most appropriate classification.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-05-19
Item 5.02
Shachi Singh resigned as Chief Legal Officer & General Counsel effective April 28, 2026, and Mohan Ananda resigned from the Board of Directors effective May 10, 2026. Both resignations are stated to be unrelated to disagreements with the Company.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-05-19
Item 3.02
The Company issued unregistered equity securities to settle material obligations: shares to ACM under Section 4(a)(2) and Rule 506 of Regulation D in satisfaction of a $6M judgment, and 39M shares to Reimer Plaintiffs under Section 3(a)(10) in settlement of litigation, capped at $2M value.
View raw filing on EDGAR →
8-K
Covenant Breach
confidence 65%
filed 2026-05-19
Item 2.03
The Company created a direct financial obligation of $2.5M under the ACM Letter Agreement and Confession of Judgment, signaling an accelerated or triggered obligation that reflects material financial distress.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-19
Item 8.01
A court order vacated a temporary restraining order and scheduled a fairness hearing for a settlement agreement conditioning issuance of settlement shares, and the Company terminated placement agent agreements with Aegis Capital in exchange for $2 million in contingent consideration securities.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
This is a clear Item 5.07 disclosure of shareholder meeting results held on May 19, 2026. The filing reports voting outcomes on three proposals: election of nine trustees, ratification of KPMG LLP as independent auditor, and advisory approval of executive compensation. The detailed vote tallies (For, Against/Withheld, Abstentions, Broker Non-Votes) for each proposal are the core content of the filing, matching the shareholder_vote_results taxonomy precisely.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-05-19
Item 2.02
Novelis Inc. issued a press release on May 19, 2026 reporting financial results for its fiscal year ended March 31, 2026, with the press release attached as Exhibit 99.1. The Item 2.02 disclosure explicitly states the company is furnishing results of operations and financial condition, which is the standard format for earnings releases. The detailed non-GAAP reconciliations (Adjusted EBITDA, Adjusted Free Cash Flow, Net Income Excluding Special Items) are typical of annual earnings disclosures.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-19
Item 8.01
Roblox announced a $3 billion share repurchase program authorized by its Board of Directors. While share buybacks are material capital allocation decisions that affect shareholder value and earnings per share, this disclosure does not fit neatly into the more specific event categories (it is not an earnings release, M&A activity, executive change, or financial restatement). The authorization itself—distinct from actual repurchases—is a significant corporate action that would inform investor assessment of capital strategy, but the taxonomy lacks a dedicated "capital allocation" or "buyback authorization" category.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-19
Item 2.03
This 8-K Item 2.03 discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds totaling $50 million across three tranches (maturing 2027–2031 with coupons of 4.0–4.35%). While Item 2.03 typically signals covenant_breach or debt acceleration events, this filing describes routine debt issuance by a Federal Home Loan Bank in the capital markets—a material but recurring operational activity that does not fit the specific covenant_breach taxonomy (which implies default or acceleration). The Bank explicitly notes that "consolidated obligations issuance is material to the Bank" but disclaims judgment on individual issuances' materiality, suggesting this is standard disclosure practice rather than an extraordinary event.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
AtriCure held its Annual Meeting of Stockholders on May 19, 2026, with shareholders voting on five proposals including director elections, auditor ratification, stock plan amendments, and an advisory compensation vote. All proposals passed with substantial majorities.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-19
Item 2.03
This disclosure reports the creation of direct financial obligations through the issuance of consolidated obligations (bonds and discount notes) by the Federal Home Loan Bank of Des Moines. While Item 2.03 typically captures covenant breaches or material debt arrangements, this filing describes routine debt issuance activity that is material to the Bank's operations but does not fit cleanly into the covenant_breach category (no breach or default is disclosed). The Bank explicitly states "consolidated obligations issuance is material to the Bank," and Schedule A details committed issuances, making this a material event that warrants disclosure but falls outside the more specific event-type categories.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-19
Item 2.03
This 8-K Item 2.03 discloses the creation of direct financial obligations through the issuance of consolidated obligations (bonds and discount notes) totaling approximately $960 million across five separate issuances in May 2026. While the filing explicitly states "consolidated obligations issuance is material to the FHLBank," the disclosure does not fit cleanly into the standard taxonomy categories. The event is a routine debt issuance by a government-sponsored enterprise (Federal Home Loan Bank), not a covenant breach, M&A activity, or other more specific event type. This is best classified as other_material given its materiality to the registrant's funding operations and balance sheet, despite being a standard capital markets activity.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-19
Item 2.03
This Item 2.03 disclosure reports the issuance of Consolidated Bonds (debt securities) totaling $81 million across six bond offerings on trade date 5/13/2026. While Item 2.03 is technically designated for "Creation of a Direct Financial Obligation," the filing itself explicitly states "although Consolidated Obligations issuance is material to the FHLB, we have not made a judgment as to the materiality of any particular Consolidated Obligation or Obligations." The disclosure is routine debt issuance reporting by a Federal Home Loan Bank, not a material event in the traditional 8-K sense (no covenant breach, no going-concern issue, no acceleration of obligations). This is a borderline case—the issuance is material in aggregate to the FHLB's operations, but the filing's own language suggests individual issuances are routine capital-markets activity. Classified as other_material rather than covenant_breach because no triggering event or financial stress is disclosed.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-19
Item 2.03
This Item 2.03 disclosure reports the issuance of consolidated obligation bonds totaling approximately $260 million across nine separate debt securities issued on trade dates of 5/13/2026 and 5/15/2026. While Item 2.03 is technically designated for "Creation of a Direct Financial Obligation," the filing itself explicitly states "although consolidated obligations issuance is material to the Bank, we have not made a judgment as to the materiality of any particular consolidated obligation or obligations." The disclosure is routine debt issuance reporting for a Federal Home Loan Bank, which regularly accesses capital markets through consolidated obligations. This does not fit the specific event types of covenant_breach (no breach indicated), ma_activity (no acquisition/merger), or other more specific categories—it is a material but routine debt issuance disclosure.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-19
Item 2.03
This Item 2.03 disclosure reports the creation of direct financial obligations through the issuance of consolidated obligations (bonds and discount notes) totaling approximately $2.185 billion across multiple tranches with varying maturities, rates, and call features. While Item 2.03 typically signals covenant_breach or debt acceleration events, this filing discloses routine debt issuances by a Federal Home Loan Bank in the ordinary course of business—a material but recurring funding activity. The disclosure emphasizes joint and several liability across all FHLBanks and provides detailed Schedule A information on each issuance, making it material to investors but not fitting the specific covenant_breach or other narrower event categories.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-19
Item 2.03
This 8-K Item 2.03 discloses the creation of direct financial obligations through the issuance of consolidated obligations (debt securities) totaling $850 million across three tranches with trade dates of 5/15/2026 and 5/19/2026. While Item 2.03 is the designated item for debt issuances, the taxonomy lacks a specific "debt_issuance" category. The filing explicitly states "consolidated obligations issuance is material to the Bank," and these obligations represent direct financial liabilities. This is classified as "other_material" rather than "covenant_breach" (which addresses defaults) because it represents routine debt capital-raising activity, albeit material in amount, that does not fit the more specific event categories provided.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-19
Item 2.03
The filing discloses the Federal Home Loan Bank of Indianapolis becoming the primary obligor on consolidated obligation bonds totaling approximately $445 million across multiple issuances with varying maturities (2028–2056) and rate structures. While Item 2.03 is technically about creation of direct financial obligations, this disclosure is most accurately characterized as a material debt issuance event. The bonds are joint and several obligations of the FHLBanks and represent a significant financial commitment, but the filing does not fit cleanly into the covenant_breach taxonomy (no breach alleged) or other more specific event types, making other_material the most appropriate classification.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-19
Item 2.03
This 8-K Item 2.03 discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds totaling approximately $920.2 million across multiple tranches with varying maturities (2026–2036) and rate structures. While the Bank explicitly states it "has not made a judgment as to the materiality of these consolidated obligation bonds," the aggregate principal amount and the nature of debt issuance—a core funding mechanism for a Federal Home Loan Bank—constitute a material event affecting the registrant's financial position. This does not fit neatly into the covenant_breach taxonomy (no breach disclosed) but represents a material creation of direct financial obligations as contemplated by Item 2.03.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-05-19
Item 1.01
Healthcare Realty Trust entered into a $400 million senior unsecured delayed draw term loan facility on May 15, 2026, with Wells Fargo as administrative agent and a syndicate of major lenders, maturing in May 2029. While structured as a financing arrangement rather than a traditional M&A transaction, this material definitive agreement substantially affects the company's capital structure and financial obligations.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
DHI Group held its Annual Meeting on May 15, 2026, at which shareholders voted on five proposals: election of two Class I directors (Art Zeile and Elizabeth Salomon), ratification of RSM US LLP as auditor, advisory vote on named executive officer compensation, and approval of amendments to the 2022 Omnibus Equity Award Plan and 2020 Employee Stock Purchase Plan. All proposals were approved by shareholders.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-05-19
Item 8.01
The filing discloses that WBD's subsidiaries have commenced consent solicitations to amend indentures governing outstanding notes in connection with the pending acquisition of WBD by Paramount Skydance Corporation. While the primary focus is the consent solicitation mechanics, the disclosure is fundamentally tied to and conditioned upon the material acquisition transaction. The forward-looking statements section explicitly references "the acquisition of WBD (the 'Acquisition') by Paramount Skydance Corporation" as a central transaction affecting the company's financial obligations and future operations, making this a material M&A-related event.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-19
Item 7.01
Granite Construction announced pricing of a $600 million private offering of senior notes due 2034. While this is a material debt issuance that would affect investor assessment of the company's capital structure and financial obligations, it does not fit cleanly into the dilutive_issuance category (which focuses on equity securities) nor any other specific event type. The disclosure is material as it represents a significant financing activity, but the taxonomy lacks a dedicated debt issuance category.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-05-19
Item 2.02
The filing discloses financial results for the fiscal quarter ended March 31, 2026 via a press release issued on May 14, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). This is a standard quarterly earnings release, which is material to investors as it provides key financial performance metrics.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-05-19
Item 7.01
The Company entered into a Memorandum of Understanding with the County of Maui regarding the sale or lease of real property and water infrastructure assets in West Maui and Upcountry Maui. Although the MOU is non-binding, it represents a material disposition of assets (water-related assets and real property) that would affect a reasonable investor's assessment of the Company's strategic direction and asset base. The disclosure emphasizes this as "an important milestone in the Company's efforts to sell certain assets" and notes the County has "initiated budget allocations toward the potential purchase," indicating substantive progress toward a material transaction.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-05-19
Item 2.02
Sypris Solutions disclosed financial results for the first quarter ended April 5, 2026, announced on May 19, 2026, with the full press release furnished as Exhibit 99 under Regulation FD.
View raw filing on EDGAR →
8-K
Other material
confidence 78%
filed 2026-05-19
Item 5.03
Kingsway Financial Services Inc. changed its corporate name to Kingsway Corporation and its ticker symbol to 'KWY' on the NYSE, effective May 19, 2026, following shareholder approval and amendments to the Certificate of Incorporation and Bylaws.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-19
Item 8.01
The filing discloses a sale of three nonperforming loans via press release on May 19, 2026. While loan sales can be routine portfolio management, the fact that Alerus Financial chose to announce this via 8-K Item 8.01 suggests materiality to investors. However, without details on the dollar amount, impact on asset quality, or strategic significance, the event does not clearly fit the more specific categories (e.g., material_impairment would require a write-down or charge; ma_activity typically involves larger acquisitions or dispositions). The disclosure is material enough to warrant 8-K filing but ambiguous in nature, making "other_material" the most appropriate classification.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
This is a clear disclosure of shareholder vote results from Waterstone Financial's 2026 Annual Meeting of Shareholders held on May 19, 2026. The filing presents detailed voting tallies for four proposals: election of three directors, ratification of auditors (Forvis Mazars, LLP), advisory approval of executive compensation, and advisory vote on compensation voting frequency. This is a quintessential Item 5.07 shareholder_vote_results event, and the outcomes are material to investors as they reflect shareholder approval of board composition, auditor selection, and executive compensation arrangements.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
This is a clear disclosure of shareholder vote results from Cathay General Bancorp's May 18, 2026 Annual Meeting of Stockholders. The filing reports voting outcomes on four matters: election of four Class III directors, advisory approval of executive compensation, frequency of future advisory votes on compensation, and ratification of KPMG LLP as independent auditor. The detailed vote tallies (for, against, abstain, broker non-votes) for each proposal are the core content of Item 5.07, which is the standard Item for reporting shareholder meeting results.
View raw filing on EDGAR →
8-K
M&A activity
confidence 89%
filed 2026-05-19
Item 1.01
Eton entered into and completed a material supply and distribution agreement with Knight Therapeutics on May 18, 2026, acquiring exclusive U.S. commercialization rights to IMPAVIDO® (miltefosine). The transaction includes $4.25 million in fixed fees through March 31, 2032, up to $4.0 million in milestone payments, and royalties of 50–55% of net sales, directly expanding Eton's product portfolio with an orphan drug that generated $8.1 million in U.S. sales in 2025.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-05-19
Item 2.02
Moving iMAGE Technologies disclosed financial results for Q1 2026 (three months ended March 31, 2026) via press release and conference call transcript attached as exhibits.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-19
Item 1.01
GeoVax Labs entered into a securities purchase agreement on May 18, 2026 for an unregistered private placement of pre-funded warrants and common warrants to purchase up to 6,081,081 shares of common stock, raising approximately $2.7 million in net proceeds under Section 4(a)(2) and Regulation D exemptions. The offering was announced via press release and will substantially increase share count upon warrant exercise, materially diluting existing shareholders.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Rush Enterprises' 2026 Annual Meeting of Shareholders. The filing presents voting outcomes for three proposals: election of nine directors, advisory approval of executive compensation, and ratification of Ernst & Young LLP as independent auditor. The detailed vote tallies (votes for, against, withheld, and broker non-votes) are the core content, making this unambiguously a shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-05-19
Item 2.02
Super League Enterprise issued a press release and hosted an earnings call on May 15, 2026 to announce financial results for the quarter ended March 31, 2026.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-19
Item 7.01
Monopar disclosed positive Phase 2 clinical trial results for ALXN1840 in Wilson disease via press release under Item 7.01 (Regulation FD Disclosure). While this is clinical progress material to investors in a biopharmaceutical company, it does not fit the "earnings_release" category (which typically covers financial results) and lacks the specificity of other event types. The disclosure of material clinical trial outcomes is a significant corporate event but is best classified as "other_material" given the taxonomy's focus on financial and governance events.
View raw filing on EDGAR →